Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3792
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18935277 | PHOTOBIOMODULATION SYSTEMS UTILIZING MONITORING OR ELECTRICAL STIMULATION AND METHODS OF MAKING AND USING | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 17833538 | ANOMALY DETECTION FOR SENSED ELECTROPHYSIOLOGICAL DATA | Final Rejection | Boston Scientific Neuromodulation Corporation |
| 18549147 | Systems And Methods For Associating Components Of A Surgical Instrument For Navigation-Assisted Surgery | Final Rejection | Stryker European Operations Limited |
| 17944628 | ELECTRODE ASSEMBLY, SYSTEMS, AND METHODS OF USE THEREOF | Non-Final OA | Stryker Corporation |
| 18038414 | SURGICAL INSTRUMENT WITH ELECTROPOLISHED TUNGSTEN CABLE | Non-Final OA | Intuitive Surgical Operations, Inc. |
| 18380750 | CONTROL CIRCUIT AND MOTOR ASSEMBLY FOR SURGICAL HANDPIECE | Final Rejection | Arthrex, Inc. |
| 18324810 | CANNULA REDUCER | Non-Final OA | Auris Health, Inc. |
| 19354875 | CIRCUMFERENTIALLY SENSING MANOMETRY SYSTEMS AND METHODS WITH CATHETER UTILIZING PRESSURE SENSITIVE MEMS | Non-Final OA | Covidien LP |
| 18561666 | STERILE ADAPTER ASSEMBLIES FOR ROBOTIC SURGICAL SYSTEMS | Final Rejection | Covidien LP |
| 17902417 | SLEEP SYSTEM WITH FEATURES FOR PERSONALIZED DAYTIME ALERTNESS QUANTIFICATION | Non-Final OA | Sleep Number Corporation |
| 17912136 | BLOOD PUMP | Non-Final OA | Abiomed Europe GmbH |
| 18794618 | LEADLESS PACEMAKERS INCLUDING A PIEZOELECTRIC DEVICE | Non-Final OA | University of Washington |
| 18282957 | SURGICAL OR ENDOSCOPIC INSTRUMENT AND PRODUCTION THEREOF | Non-Final OA | KARL STORZ SE & Co. KG |
| 18191756 | EYEBALL AND EYELID PROTECTOR | Final Rejection | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18671513 | WEARABLE DEVICE AND METHOD FOR PROVIDING SMOKING EFFECT | Non-Final OA | KT&G CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy